Clinical Trial Update: A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for GenSci134 in children with growth hormone deficiency; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• GenSci134

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Pediatric Growth Hormone Deficiency | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING